Bioline Rx reported $200.5M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 1.47B 537M Dec/2025
Bio Path USD 1000K 0 Sep/2025
Bioline Rx USD 16M 40M Sep/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025